Kwality Pharmaceuticals Limited (NSE:KPL)

Kwality Pharmaceuticals Ratios and Metrics

Market cap in millions INR. Fiscal year is April - March.

Fiscal Year	Current	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May 21, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Market Capitalization	22,155	13,555	9,017	4,248	3,191	6,018
Market Cap Growth	196.78%	50.32%	112.27%	33.12%	-46.97%	935.71%
Enterprise Value	23,407	14,302	9,948	5,076	4,145	6,180
PE Ratio	32.90	20.13	22.63	17.85	16.47	5.02
PS Ratio	4.40	2.69	2.44	1.38	1.27	1.32
PB Ratio	6.72	4.11	3.44	1.91	1.60	3.35
P/TBV Ratio	6.80	4.16	3.44	1.90	1.59	3.32
P/FCF Ratio	-	-	30.65	32.33	-	110.54
P/OCF Ratio	133.57	81.72	17.11	9.88	7.71	9.93
EV/Sales Ratio	4.65	2.84	2.69	1.65	1.65	1.36
EV/EBITDA Ratio	19.33	11.81	12.13	7.46	6.73	3.56
EV/EBIT Ratio	23.11	14.12	15.61	10.48	8.88	3.80
EV/FCF Ratio	-83.55	-	33.81	38.62	-	113.51
Debt / Equity Ratio	0.40	0.40	0.43	0.44	0.45	0.35
Debt / EBITDA Ratio	1.08	1.08	1.37	1.44	1.46	0.36
Debt / FCF Ratio	-	-	3.82	7.47	-	11.61
Net Debt / Equity Ratio	0.39	0.39	0.37	0.41	0.42	0.28
Net Debt / EBITDA Ratio	1.05	1.05	1.19	1.36	1.35	0.29
Net Debt / FCF Ratio	-4.53	-4.53	3.32	7.01	-13.18	9.23
Asset Turnover	0.97	0.97	0.88	0.82	0.72	1.80
Inventory Turnover	3.20	3.20	2.33	1.92	1.63	4.88
Quick Ratio	1.30	1.30	1.07	0.90	0.68	0.65
Current Ratio	1.80	1.80	1.67	1.60	1.65	1.63
Return on Equity (ROE)	22.74%	22.74%	16.41%	11.20%	10.18%	100.10%
Return on Assets (ROA)	12.18%	12.18%	9.47%	8.10%	8.40%	40.13%
Return on Invested Capital (ROIC)	18.55%	18.66%	13.89%	12.33%	13.75%	75.28%
Return on Capital Employed (ROCE)	27.60%	27.60%	23.00%	20.00%	20.50%	80.90%
Earnings Yield	3.04%	4.97%	4.42%	5.60%	6.07%	19.94%
FCF Yield	-1.26%	-2.07%	3.26%	3.09%	-1.97%	0.91%
Buyback Yield / Dilution	-0.01%	-0.01%	-	-	-	-0.00%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.